Keya Medical Announces Strategic Partnerships to Expand Coverage in the US
Keya Medical North America is set to enhance its presence in the United States through a series of strategic partnerships.
Advances in Heart Imaging – “The Depths of the Heart” by Keith Loria in Radiology Today
Advances in heart imaging and cardiovascular care. “The Depths of the Heart” by Keith Loria in Radiology Today.
Keya Medical’s CT FFR analysis DEEPVESSEL® is now available in the USA.
Deep-learning-based, non-invasive, accurate, and accessible FFR CT analysis DEEPVESSEL FFR is now available in the USA.
DEEPVESSEL FFR, Keya Medical Deep-Learning Based, Non-Invasive Coronary Artery Functional Assessment Software Device, Receives FDA Clearance.
Seattle, WA– April 1, 2022– Keya Medical announced that DEEPVESSEL FFR (DVFFR), has been cleared by U.S. Food and Drug Administration (FDA).
DeepVessel 3D Visualization Processing Software Receives Regulatory Approval in China
Keya Medical has received regulatory approval in China for its DeepVessel 3D Visualization Processing Software. The AI-based software medical device is designed for visualization reading of multiphase CT images and 3D models.
Keya Medical Raises $46M in Series D Round
Keya Medical has raised $46 million in Series D funding. This funding round was led by new and existing investors, including CICC Capital, Shanghai Artificial Intelligence Investment Fund, Qianhai Gaozu Asset Management Fund, and IN CAPITAL.
Recent Comments